Clinical studies recruiting near Portland

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Providence Portland Medical Center · Eli Lilly and Company · NCT07218380 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Providence St. Vincent Medical Center · Joseph Broderick, MD · NCT07227246 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · OHSU Dept of Nephrology · Novartis Pharmaceuticals · NCT05755386 A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Phase 1 · Providence Portland Medical Center · Johnson & Johnson Enterprise Innovation Inc. · NCT06116786 Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Phase N/A · Oregon Health and Science University · Arkansas Children's Hospital Research Institute · NCT03827694 Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced In
Phase 1 · OHSU Knight Cancer Institute · OHSU Knight Cancer Institute · NCT07548983 Hearing Aids for Veterans With Functional Hearing Difficulties
NA · VA Portland Health Care System, Portland, OR · VA Office of Research and Development · NCT06117254 A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · Oregon Health & Science University (OHSU) - Nephrology and H · Takeda · NCT06747351 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Local Institution - 0141 · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Providence Portland Medical Center ( Site 0116) · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · MaineHealth Maine Medical Center - Portland · National Cancer Institute (NCI) · NCT05564390 Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC
Phase 1 · Portland Providence Medical Center · Providence Health & Services · NCT04470024 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Legacy Emanuel Children's Hospital · National Cancer Institute (NCI) · NCT05099003 Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
NA · Oregon Health and Sciences University · Washington University School of Medicine · NCT05991453 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Maine Medical Center · Pfizer · NCT06758401 Safety and Target Engagement of Centella Asiatica in Cognitive Impairment
Phase 1 · Oregon Health & Science University · Oregon Health and Science University · NCT05591027 Use of Cervical Cap and Menstrual Disc for Application of Topical Anesthetic Prior to IUD Insertion
NA · Oregon Health & Science University · Oregon Health and Science University · NCT06891794 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Legacy Emanuel Children's Hospital · National Cancer Institute (NCI) · NCT06172296 Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial
Phase N/A · OHSU Knight Cancer Institute · OHSU Knight Cancer Institute · NCT07726602 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Summit Research Network · Kallyope Inc. · NCT07674654 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · MaineHealth Maine Medical Center - Portland · NRG Oncology · NCT05624996 A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
Phase N/A · Oregon Health and Science University · ITF Therapeutics LLC · NCT07127978 A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Pa
Phase 4 · Oregon Dermatology and Research Center · Eli Lilly and Company · NCT06857942 Treatment With Endovascular Intervention for STroke Patients With Existing Disability
Phase N/A · Providence St. Vincent Medical Center · University of Cincinnati · NCT05911568 PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Phase 3 · Oregon Health and Sciences University · Duke University · NCT07232069 A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Ag
Phase 3 · Maine Health - Maine Medical Center · Travere Therapeutics, Inc. · NCT06247085 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Oregon Health and Science University · Hoffmann-La Roche · NCT06793215 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · MaineHealth Maine Medical Center - Portland · Alliance for Clinical Trials in Oncology · NCT07321652 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Providence Portland Medical Center · Bristol-Myers Squibb · NCT07291076 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Doernbecher Children's Hospital · PedAL BCU, LLC · NCT05183035

Look up another city

Look up another condition